Overview
Availability
- Dr Lisette Pregelj is:
- Available for supervision
Qualifications
- Bachelor (Honours) of Biotechnology, The University of Queensland
- Masters (Coursework), The University of Queensland
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Lisette Pregelj’s works on UQ eSpace
2024
Journal Article
Material Trends and Clinical Costings in Systematically Identified CDER‐Approved Nanomedicines
Jarrett, Thomas Ryan, Pregelj, Lisette, Bell, Craig Andrew, Fletcher, Nicholas Lyle and Thurecht, Kristofer James (2024). Material Trends and Clinical Costings in Systematically Identified CDER‐Approved Nanomedicines. Advanced Therapeutics. doi: 10.1002/adtp.202400124
2024
Journal Article
Anticipatory regulation for pandemic responses: are we there yet?
Oyola-Lozada, Maria Giuliana, Pregelj, Lisette, Jenkins, Anna, Siegel, Evan, Munro, Trent and Hine, Damian (2024). Anticipatory regulation for pandemic responses: are we there yet?. Trends in Biotechnology, 42 (9), 1067-1071. doi: 10.1016/j.tibtech.2024.02.016
2024
Journal Article
Are manufacturing patents to blame for biosimilar market launch delays?
Williamson, Rhys, Munro, Trent, Ascher, David, Robertson, Avril and Pregelj, Lisette (2024). Are manufacturing patents to blame for biosimilar market launch delays?. Value in Health, 27 (3), 287-293. doi: 10.1016/j.jval.2023.12.005
2023
Journal Article
Delivering impactful solutions for the bioeconomy
Hankamer, Ben, Pregelj, Lisette, O’Kane, Shane, Hussey, Karen and Hine, Damian (2023). Delivering impactful solutions for the bioeconomy. Trends in Plant Science, 28 (5), 583-596. doi: 10.1016/j.tplants.2023.02.007
2023
Journal Article
Restoring Australia’s long-term innovation requires investment in basic research
Harrison, Rosemary S., Barnard, Ross T. and Pregelj, Lisette (2023). Restoring Australia’s long-term innovation requires investment in basic research. Microbiology Australia, 44 (1), 57-61. doi: 10.1071/ma23014
2022
Other Outputs
Interviews
Oyola Lozada, Giuliana, Jenkins, Anna, Pregelj, Lisette and MacAulay, Sam (2022). Interviews. The University of Queensland. (Dataset) doi: 10.48610/4ef737d
2021
Journal Article
Assessing the Impact of US Food and Drug Administration Breakthrough Therapy designation timing on trial characteristics and development speed
Pregelj, Lisette, Hine, Damian C., Kesselheim, Aaron S. and Darrow, Jonathan J. (2021). Assessing the Impact of US Food and Drug Administration Breakthrough Therapy designation timing on trial characteristics and development speed. Clinical Pharmacology and Therapeutics, 110 (4) cpt.2318, 1018-1024. doi: 10.1002/cpt.2318
2021
Other Outputs
Adaptive regulation for digital health: enhancing Australia’s regulation system
Stephens, Anna, Pregelj, Lisette, Hine, Damian and Smith, Alexander (2021). Adaptive regulation for digital health: enhancing Australia’s regulation system. Brighton, VIC, Australia: MTPConnect.
2020
Journal Article
Working hard or hardly working? Regulatory bottlenecks in developing a COVID-19 vaccine
Pregelj, Lisette, Hine, Damian C., Oyola-Lozada, Maria G. and Munro, Trent P. (2020). Working hard or hardly working? Regulatory bottlenecks in developing a COVID-19 vaccine. Trends in Biotechnology, 38 (9), 943-947. doi: 10.1016/j.tibtech.2020.06.004
2018
Conference Publication
Trading-off innovation speed for knowledge during drug development
Pregelj, Lisette, Hine, Damian Charles, Becerra, Manuel and Verreynne, Martie-Louise (2018). Trading-off innovation speed for knowledge during drug development. Academy of Management Annual Meeting, Chicago, IL United States, 10-14 August 2018. Briarcliff Manor, NY United States: Academy of Management. doi: 10.5465/ambpp.2018.15704abstract
2018
Journal Article
Precision medicines have faster approvals based on fewer and smaller trials than other medicines
Pregelj, Lisette, Hwang, Thomas J., Hine, Damian C., Siegel, Evan B., Barnard, Ross T., Darrow, Jonathan J. and Kesselheim, Aaron S. (2018). Precision medicines have faster approvals based on fewer and smaller trials than other medicines. Health affairs (Project Hope), 37 (5), 724-731. doi: 10.1377/hlthaff.2017.1580
2018
Book Chapter
Commercializing university research to mitigate simultaneous change stimuli: an exemplar case from the Australian higher education sector
Hine, Damian, Pregelj, Lisette and McManus, Michael (2018). Commercializing university research to mitigate simultaneous change stimuli: an exemplar case from the Australian higher education sector. World scientific reference on innovation. (pp. 97-112) edited by Donald Siegel. Singapore: World Scientific . doi: 10.1142/9789813149045_0006
2015
Journal Article
Changes in clinical trial length
Pregelj, Lisette, Verreynne, Martie-Louise and Hine, Damian (2015). Changes in clinical trial length. Nature Reviews Drug Discovery, 14 (5), 307-308. doi: 10.1038/nrd4611
2013
Journal Article
Deconstructing and reconstructing the capability hierarchy
Hine, Damian, Parker, Rachel, Pregelj, Lisette and Verreynne, Martie-Louise (2013). Deconstructing and reconstructing the capability hierarchy. Industrial and Corporate Change, 23 (5), 1299-1325. doi: 10.1093/icc/dtt046
2013
Other Outputs
Capability development along the capability lifecycle: Evidence from the pharmaceutical industry
Pregelj, Lisette (2013). Capability development along the capability lifecycle: Evidence from the pharmaceutical industry. PhD Thesis, UQ Business School, The University of Queensland.
2012
Other Outputs
Brisbane Innovation Scorecard 2012. Brisbane City Council and Brisbane Marketing Economic Development Board
Steen, John, Verreynne, Martie-Louise, Pregelj, Lisette, Foster, Mishka and Cretchley, Julia (2012). Brisbane Innovation Scorecard 2012. Brisbane City Council and Brisbane Marketing Economic Development Board. Brisbane, Australia: Brisbane Marketing.
2011
Journal Article
Transcription profiling of the isoflavone phenylpropanoid pathway in soybean in response to Bradyrhizobium japonicum inoculation
Pregelj, Lisette, McLanders, Joanne R., Gresshoff, Peter M. and Schenk, Peer M. (2011). Transcription profiling of the isoflavone phenylpropanoid pathway in soybean in response to Bradyrhizobium japonicum inoculation. Functional Plant Biology, 38 (1), 13-24. doi: 10.1071/FP10093
2011
Book Chapter
Small pharmaceutical firms building capabilities to compete along the global research and development pipeline
Pregelj, Lisette, Verreynne, Martie-Louise and Hine, Damian (2011). Small pharmaceutical firms building capabilities to compete along the global research and development pipeline. International entrepreneurship in the life sciences. (pp. 64-100) edited by Marian V. Jones, Colin Wheeler and Pavlos Dimitratos. Cheltenham United Kingdom: Edward Elgar Publishing.
2011
Conference Publication
Capability development in the pharmaceutical commercialisation process
Pregelj, Lisette, Verreynne, Martie-Louise and Hine, Damian (2011). Capability development in the pharmaceutical commercialisation process. 14th Asia-Pacific Researchers in Organization Studies Conference (APROS 2011), Auckland, New Zealand, 28 November - 1 December 2011. Auckland, New Zealand: Auckland University of Technology.
2010
Conference Publication
Capability building in the pharmaceutical industry
Hine, D., Pregelj, L. and Verreynne, M. (2010). Capability building in the pharmaceutical industry. Strategic Management Society Conference, Rome, Italy, 12-15 September, 2010.
Funding
Past funding
Supervision
Availability
- Dr Lisette Pregelj is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Biosimilar litigation and market entry
Principal Advisor
Other advisors: Emeritus Professor Stephen Mahler, Professor Avril Robertson
-
Doctor Philosophy
Disruptive innovation: How can it be valued and priced? A case of novel theranostics in oncology
Associate Advisor
Other advisors: Dr Sam MacAulay, Dr Anna Jenkins
Completed supervision
-
2024
Doctor BioTechnology
Development of the algae sector through business model innovation
Principal Advisor
Other advisors: Dr Edgar Brea
-
2020
Doctor BioTechnology
Investigating Trends in the Duration of the Regulatory Approval Phase for Biosimilars in the European Union and the United States of America
Associate Advisor
Other advisors: Professor Damian Hine, Emeritus Professor Ross Barnard
Media
Enquiries
For media enquiries about Dr Lisette Pregelj's areas of expertise, story ideas and help finding experts, contact our Media team: